Lim Diane C, Sutherland Kate, Cistulli Peter A, Pack Allan I
Division of Sleep Medicine/Department of Medicine, Center for Sleep and Circadian Neurobiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
Respirology. 2017 Jul;22(5):849-860. doi: 10.1111/resp.13063. Epub 2017 May 5.
P4 medicine is an evolving approach to personalized medicine. The four Ps offer a means to: Predict who will develop disease and co-morbidities; Prevent rather than react to disease; Personalize diagnosis and treatment; have patients Participate in their own care. P4 medicine is very applicable to obstructive sleep apnoea (OSA) because each OSA patient has a different pathway to disease and its consequences. OSA has both structural and physiological mechanisms with different clinical subgroups, different molecular profiles and different consequences. This may explain why there are different responses to alternative therapies, such as intraoral devices and hypoglossal nerve stimulation therapy. Currently, technology facilitates patients to participate in their own care from screening for OSA (snoring and apnoea apps) to monitoring response to therapy (sleep monitoring, blood pressure, oxygen saturation and heart rate) as well as monitoring their own continuous positive airway pressure (CPAP) compliance. We present a conceptual framework that provides the basis for a new, P4 medicine approach to OSA and should be considered more in depth: predict and prevent those at high risk for OSA and consequences, personalize the diagnosis and treatment of OSA and build in patient participation to manage OSA.
精准医疗是个性化医疗的一种不断发展的方法。这四个“P”提供了一种手段,用于:预测谁会患疾病和共病;预防疾病而非对疾病做出反应;使诊断和治疗个性化;让患者参与自身护理。精准医疗非常适用于阻塞性睡眠呼吸暂停(OSA),因为每个OSA患者患疾病及其后果的途径都不同。OSA具有结构和生理机制,存在不同的临床亚组、不同的分子特征和不同的后果。这或许可以解释为什么对诸如口腔矫治器和舌下神经刺激疗法等替代疗法会有不同的反应。目前,技术有助于患者参与自身护理,从OSA筛查(打鼾和呼吸暂停应用程序)到监测治疗反应(睡眠监测、血压、血氧饱和度和心率)以及监测自身持续气道正压通气(CPAP)依从性。我们提出一个概念框架,为一种新的针对OSA的精准医疗方法提供基础,应更深入地加以考虑:预测并预防OSA及其后果的高危人群,使OSA的诊断和治疗个性化,并让患者参与OSA的管理。